---
document_datetime: 2023-09-21 19:05:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kyprolis-epar-all-authorised-presentations_en.pdf
document_name: kyprolis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.750737
conversion_datetime: 2025-12-27 16:57:35.938228
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU (MA) Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/15/1060/001   | Kyprolis   | 60 mg   | Powder for solution for infusion   | Intravenous use   | vial (glass)   | 60 mg/30 mL (2 mg/mL)   | 1 vial   |
|--------------------|------------|---------|------------------------------------|-------------------|----------------|-------------------------|----------|
| EU/1/15/1060/002   | Kyprolis   | 10 mg   | Powder for solution for infusion   | Intravenous use   | vial (glass)   | 10 mg/5 mL (2 mg/mL)    | 1 vial   |
| EU/1/15/1060/003   | Kyprolis   | 30 mg   | Powder for solution for infusion   | Intravenous use   | vial (glass)   | 30 mg/15 mL (2 mg/mL)   | 1 vial   |